  Succinylcholine and Burn Patients section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; }

### Succinylcholine (SCh) and Burn Patients

SCh is safe to administer in the first 24 hours after a burn.

The burns to be concerned with are those that are 3rd-degree burns covering more than 25% of the body.

Current literature supports avoiding SCh 48 hours post-burn incident.

Traditionally, SCh administered > 24 post burn is contraindicated due to the risk of hyperkalemia leading to cardiac arrest.

Etiology:

The upregulation of extrajunctional nicotinic acetylcholine receptors (nAChRs)

may cause severe hyperkalemia as a result of potassium efflux into the bloodstream

from the prolonged depolarization after the administration of SCh.

Refer to _“ Succinylcholine –Up Regulation of Nicotinic Acetylcholine Receptors.”_

This sensitivity can persist up to one year post-burn.

Some literature states 24 hours to 2 years.

Anesthesia providers usually avoid administering SCh to burn patients either way.

Blanchet B, Julien V, Vinsonneau C, Tod M. Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn

patients. Clin Pharmacokinet. 2008;47(10):635-654.

Anesthetic Management of Patients With Major Burn Injury

By _Kimy R. Harbin, CRNA, MSN Teresa E. Norris, CRNA, EdD_

https://www.aana.com/newsandjournal/Documents/anes-mnge-burn-1212-p430-439.pdf